Identification of Preoperative Parameters to Predict Acute Kidney Injury Risk Following Vascular or Digestive Surgery
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Dec 13, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is looking to understand how certain health factors before surgery can help predict the risk of acute kidney injury (AKI) after patients undergo vascular or digestive surgery. The study is taking place at the Besançon University Hospital and aims to use a scoring system called the SPARK score to identify these important preoperative factors.
To be eligible for this study, participants must be undergoing digestive or vascular surgery at the hospital during specific time frames in 2019 or 2023. However, some patients may not qualify, such as those who have had recent kidney issues, are having outpatient surgery, or require emergency surgery due to bleeding. If you choose to participate, you can expect to provide information about your health before surgery, which researchers will use to better understand AKI risks. This study is important because identifying at-risk patients could lead to better care and outcomes after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Digestive surgery or vascular surgery at Besancon University Hospital between 01/01/2019 and 31/12/2019 (retrospective) or between 01/01/2023 and 31/12/2023 (prospective)
- Exclusion Criteria:
- • No preoperative creatinine value
- • Outpatient surgery
- • Surgery other than digestive or vascular (organ procurement surgery/nephrectomy surgery/renal transplantation)
- • Kidney/urinary tract surgery
- • Arteriovenous fistula surgery
- • End-stage renal disease or renal replacement therapy, except for renal transplant patients
- • Acute kidney injury KDIGO≥1 within 2 weeks before surgery
- • Patients in need of emergency surgery for ongoing haemorrhage
- • Legal incapacity or limited legal capacity
- • Subjects with no social security coverage.
Trial Officials
Cécile Courivaud, Prof.
Principal Investigator
Centre Hospitalier Universitaire de Besançon
About Centre Hospitalier Universitaire De Besancon
The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Besançon, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials